It’s increasingly vital for corporate scientific teams to get a full picture of their research’s reach and influence. These insights can help you build a case for future investment, refine your research and communication strategies, and connect with key online influencers. But how do you uncover this full picture – and how do you get the data in a way that’s easy to understand and tailored to your needs? 

Bespoke dashboards built with Altmetric and Dimensions data use established concepts like Share of Voice to and Key Opinion Leader to create a data-driven approach that helps you benchmark your company’s scientific position, drive research engagement across multiple channels and audiences, and make sound strategic decisions

In a recent webinar, Digital Science’s Head of Data Insights Mike Taylor showed the dashboard in action.

The Share of Voice dashboard

Corporate scientists, such as those in pharma companies, have long used both Altmetric and Dimensions to track and understand the reach and impact of their research. Dimensions allows you to search publications, datasets, grants, patents and clinical trials, seeing the data in context and tracing the relationships between their results. Altmetric scours the internet for places where people are mentioning, discussing research and clinical trials, then mines the insights so you can make sense of it. 

But the increased virtualization triggered by the Covid-19 pandemic made it harder for firms to track the research and clinical trials they were supporting. In response to these challenges, the Altmetric Data Insights team developed the Share of Voice dashboard. Providing a unique view of a company’s share of voice in a research area, the dashboard has enabled companies to measure for the first time how patients, doctors and the public are engaging with research that mentions their products.

The Share of Voice dashboard combines data from Dimensions and Altmetric. Dimensions provides traditional share of voice metrics from publication and clinical trial data (spanning 120 million publications and 650K clinical trials); Altmetric trawls sources from social media to news stories, using advanced text and data mining to provide valuable insights into research coverage and conversations.

Radar chart showing different market share for five different therapeutics in the area of small cell lung cancer

Precision customisation

A game-changing benefit is that you’re able to customise the input with great precision, slicing and dicing it to match your specific needs. You can opt for a broad overview picture, or zoom in with a very specific and narrow focus. For example, you might include one or more therapeutic areas (TA) and a variety of products (including your competitors’ products). You can filter the results in multiple ways, from publication year to journal name, clinical trial and geographical region. And any time you adjust a filter, you’ll see the results update instantly.   

Uncovering deeper insights

The tool will first deliver an overview of your share of voice: for example, it can show the share of different therapeutics in news stories, clinical trials and Twitter activity. You can then drill down into highly detailed data, revealing a wide range of actionable insights. Some examples:

  • which news sources have given you the most coverage 
  • any differences in coverage by news sources and social media
  • how results compare according to factors like the number of researchers involved, the age of publication, or the number of clinical trials
  • the impact of mentions by opinion leaders, and which of them have had the most influence
News outlets by volume of stories for five different therapeutics in the area of small cell lung cance

Another groundbreaking feature is the scale of the data that’s mined. Dimensions currently has 120 million research publications indexed, compared with 33 million on PubMed. As a result, you are much less likely to miss whole swathes of research.  

Stay up to date with the latest from Dimensions, sign up to our mailing list below